• Join
  • Login
  • Contact

Search abstracts

Design Design of de novo designed molecules at the Peroxisome Proliferator Activated Receptor

  • At: Dublin (Ireland) (2013)
  • Type: Poster
  • By: SHOEMAKE, Claire (University of Malta, Pharmacy, Msida, Malta)
  • Co-author(s): Portelli, Stephanie (University of Malta, Msida, Malta)
    Azzopardi, Lilian (University of Malta, Msida, Malta)
  • Abstract:


    Rosiglitazone withdrawal from the markethas led to a renewed interest in the Peroxisome Proliferator Activated Receptor ã (PPARã) as target for type 2 diabetes therapies, mainly via partial agonism. This may be achieved via selective PPARã modulators such as S-26948.


    To obtain and optimise molecules having a high affinity to PPARã


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses